Clin2
NCT06539832Possibly a fitRecruiting

Gut bacteria and immunity in people with an abnormal blood protein

Multiple MyelomaMGUSGut MicrobiotaInfectionsM-Protein

Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Infections clinical trials.

This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
45 years and older
Study type
Observational

Who can take part

  • You are 45 years or older.
  • Your blood test showed no abnormal monoclonal protein (monoclonal gammaglobulin).
  • You have no signs of infection (normal blood tests for infection).
  • You have not taken antibiotics in the past month.
  • You have no history of bowel tumors, irritable bowel syndrome, or inflammatory bowel disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06690593Recruiting
Gut Microbiome Study for Healthy Adults Age 45+

This study compares the gut bacteria of healthy adults (age 45+) with those who have a blood condition called monoclonal gammopathy. The goal is to see if gut bacteria patterns differ between the two groups.

Guanzhou, Guangdong
NCT05686447Recruiting
Testing blood samples to study multiple myeloma

This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.

Guangzhou, Guangdong
NCT06750965Not yet recruiting
Blood test screening for older adults

This trial is screening people over 30 to find a protein in the blood called M protein, which can be a sign of certain blood conditions. If you have it, the study will follow you over time to learn more.

NCT06976476Recruiting· Phase 2
A study of IgPro20 to prevent infections in myeloma patients

This trial tests if a medicine called IgPro20 can help prevent infections in people with multiple myeloma who have low antibody levels and are being treated with a bispecific antibody. If you have relapsed or refractory myeloma and have recently started a bispecific antibody, this study might help protect you from getting serious infections.

Basking Ridge, New Jersey
NCT06237803Recruiting
Blood sample collection for plasma cell disorders

This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.

Melbourne
NCT04702932Not yet recruiting
Study blood sample features in certain fever-related blood diseases

This study looks at genetic and other traits of tumor/blood cells in adults with specific blood conditions who have fevers with unclear cause plus symptoms like rash or joint pain. The goal is to better understand what drives these “hyperinflammatory” reactions and how to tell them apart from other illnesses.

Paris

Hear when a new Multiple myeloma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.